HORIZON-HLTH-2023-DISEASE-07

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• INSERM1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• INSERM1 projects · FR
• AUH1 projects · DK
• UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
• Leiden University Medical Center1 projects · NL
• ACU1 projects · TR
• ANR1 projects · FR
• CZECH HEALTH RESEARCH COUNCIL1 projects · CZ
• AICIB1 projects · PT
• AIT1 projects · AT
• AFM1 projects · FR

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• ASTRAZENECA AB1 projects · company
• BKUS CHILDREN S UNIVERSITY HOSPITAL1 projects · company
• CENTOGENE GMBH1 projects · company
• CHECKIMMUNE1 projects · sme
• Copenhagen Economics1 projects · sme
• ELS1 projects · company
• ROCHE1 projects · company
• FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED1 projects · company
• HIPRA HUMAN HEALTH SL1 projects · company
• LABORATORIO REIG JOFRE SA1 projects · company
• LABORATORIOS HIPRA SA1 projects · company
• MILTENYI BIOTEC BV & CO KG1 projects · company

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 178 · avg 178

range 178 – 178 organisations

Country spread (sample)

18 countries

176–180 partner organisations (from median 178.0 in this call’s projects) · 18 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• ERDERA€56,317,413